Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links

Nucleic Acids Research

Volumn 34, Issue 9, 2006, Pages 2751-2760

  Cheng, Wen Hsing ^c   Kusumoto, Rika ^c   Opresko, Patricia L ^c,d   Sui, Xiu Fen ^c   Huang, Shurong ^a,e   Nicolette, Matthew L ^b   Paull, Tanya T ^b   Campisi, Judith ^a   Seidman, Michael ^c   Bohr, Vilhelm A ^c  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; DNA; EXONUCLEASE; HELICASE; WERNER SYNDROME PROTEIN; CROSS LINKING REAGENT; PSORALEN; RECQ HELICASE; WRN PROTEIN, HUMAN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; ENZYME ACTIVATION; ENZYME ACTIVITY; HOLLIDAY JUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; CELL PROLIFERATION; DNA DAMAGE; DRUG ANTAGONISM; GENETICS; HELA CELL; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

BRCA1 PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CROSS-LINKING REAGENTS; DNA DAMAGE; DNA HELICASES; DNA REPAIR; EXONUCLEASES; FICUSIN; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; RECQ HELICASES; RNA INTERFERENCE;

EID: 33646937737     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl362     Document Type: Article

References (54)

1. West,S.C. (2003) Molecular views of recombination proteins and their control. Nature Rev. Mol. Cell Biol., 4, 435-445.
2. Majumdar,A., Puri,N., Cuenoud,B., Natt,F., Martin,P., Khorlin,A., Dyatkina,N., George,A.J., Miller,P.S. and Seidman,M.M. (2003) Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide. J. Biol. Chem., 278, 11072-11077.
3. Dronkert,M.L. and Kanaar,R. (2001) Repair of DNA interstrand cross-links. Mutat. Res., 486, 217-247.
4. Cheng,W.H., von Kobbe,C., Opresko,P.L., Arthur,L.M., Komatsu,K., Seidman,M.M., Carney,J.P. and Bohr,V.A. (2004) Linkage between werner syndrome protein and the Mre11 complex via Nbs1. J. Biol. Chem., 279, 21169-21176.
5. Zhong,Q., Chen,C.F., Li,S., Chen,Y., Wang,C.C., Xiao,J., Chen,P.L., Sharp,Z.D. and Lee,W.H. (1999) Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science, 285, 747-750.
6. Dong,Y., Hakimi,M.A., Chen,X., Kumaraswamy,E., Cooch,N.S., Godwin,A.K. and Shiekhattar,R. (2003) Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol. Cell, 12, 1087-1099.
7. Scully,R., Chen,J., Plug,A., Xiao,Y., Weaver,D., Feunteun,J., Ashley,T. and Livingston,D.M. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88, 265-275.
8. Sakamoto,S., Nishikawa,K., Heo,S.J., Goto,M., Furuichi,Y. and Shimamoto,A. (2001) Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51. Genes Cells, 6, 421-430.
9. Bohr,V.A., Souza,P.N., Nyaga,S.G., Dianov,G., Kraemer,K., Seidman,M.M. and Brosh,R.M.,Jr (2001) DNA repair and mutagenesis in Werner syndrome. Environ. Mol. Mutagen., 38, 227-234.
10. Folias,A., Matkovic,M., Bruun,D., Reid,S., Hejna,J., Grompe,M., D'Andrea,A. and Moses,R. (2002) BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet., 11, 2591-2597.
11. Garcia-Higuera,I., Taniguchi,T., Ganesan,S., Meyn,M.S., Timmers,C., Hejna,J., Grompe,M. and D'Andrea,A.D. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell, 7, 249-262.
12. Bhattacharyya,A., Ear,U.S., Koller,B.H., Weichselbaum,R.R. and Bishop,D.K. (2000) The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J. Biol. Chem., 275, 23899-23903.
13. Venkitaraman,A.R. (2004) Tracing the network connecting BRCA and Fanconi anaemia proteins. Nature Rev. Cancer, 4, 266-276.
14. Prince,P.R., Emond,M.J. and Monnat,R.J.,Jr (2001) Loss of Werner syndrome protein function promotes aberrant mitotic recombination. Genes Dev., 15, 933-938.
15. Moynahan,M.E., Chiu,J.W., Koller,B.H. and Jasin,M. (1999) Brca1 controls homology-directed DNA repair. Mol. Cell, 4, 511-518.
16. 2/M checkpoint by activating Chk1 kinase upon DNA damage. Nature Genet., 30, 285-289.
17. 2 phase decatenation checkpoint is defective in Werner syndrome cells. Cancer Res., 63, 3289-3295.
18. Zhou,C., Huang,P. and Liu,J. (2005) The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells. Biochem. Biophys. Res. Commun., 336, 952-960.
19. Cousineau,I., Abaji,C. and Belmaaza,A. (2005) BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: Implications for sister chromatid cohesion, genome stability and carcinogenesis. Cancer Res., 65, 11384-11391.
20. Levran,O., Attwooll,C., Henry,R.T., Milton,K.L., Neveling,K., Rio,P., Batish,S.D., Kalb,R., Velleuer,E., Barral,S. et al. (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nature Genet., 37, 931-933.
21. Levitus,M., Waisfisz,Q., Godthelp,B.C., de,V.Y., Hussain,S., Wiegant,W.W., Elghalbzouri-Maghrani,E., Steltenpool,J., Rooimans,M.A., Pals,G. et al. (2005) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nature Genet., 37, 934-935.
22. Orren,D.K., Brosh,R.M.,Jr, Nehlin,J.O., Machwe,A., Gray,M.D. and Bohr,V.A. (1999) Enzymatic and DNA binding properties of purified WRN protein: High affinity binding to single-stranded DNA but not to DNA damage induced by 4NQO. Nucleic Acids Res., 27, 3557-3566.
23. Paull,T.T., Cortez,D., Bowers,B., Elledge,S.J. and Gellert,M. (2001) Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. USA, 98, 6086-6091.
24. Chen,L., Huang,S., Lee,L., Davalos,A., Schiestl,R.H., Campisi,J. and Oshima,J. (2003) WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell, 2, 191-199.
25. Majumdar,A., Khorlin,A., Dyatkina,N., Lin,F.L., Powell,J., Liu,J., Fei,Z., Khripine,Y., Watanabe,K.A., George,J. et al. (1998) Targeted gene knockout mediated by triple helix forming oligonucleotides. Nature Genet., 20, 212-214.
26. Rothfuss,A. and Grompe,M. (2004) Repair kinetics of genomic interstrand DNA cross-links: Evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell Biol., 24, 123-134.
27. Cheng,W.H., von Kobbe,C., Opresko,P.L., Fields,K.M., Ren,J., Kufe,D. and Bohr,V.A. (2003) Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution. Mol. Cell Biol., 23, 6385-6395.
28. Opresko,P.L., Laine,J.P., Brosh,R.M.,Jr, Seidman,M.M. and Bohr,V.A. (2001) Coordinate action of the helicase and 3′ to 5′ exonuclease of Werner Syndrome protein. J. Biol. Chem., 276, 44677-44687.
29. Mohaghegh,P., Karow,J.K., Brosh,J.R.,Jr, Bohr,V.A. and Hickson,I.D. (2001) The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res., 29, 2843-2849.
30. Poot,M., Yom,J.S., Whang,S.H., Kato,J.T., Gollahon,K.A. and Rabinovitch,P.S. (2001) Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J., 15, 1224-1226.
31. Poot,M., Gollahon,K.A., Emond,M.J., Silber,J.R. and Rabinovitch,P.S. (2002) Werner syndrome diploid fibroblasts are sensitive to 4-nitroquinoline-N- oxide and 8-methoxypsoralen: Implications for the disease phenotype. FASEB J., 16, 757-758.
32. Fujiwara,Y., Higashikawa,T. and Tatsumi,M. (1977) A retarded rate of DNA replication and normal level of DNA repair in Werner's syndrome fibroblasts in culture. J. Cell Physiol., 92, 365-374.
33. Simons,A.M., Horwitz,A.A., Starita,L.M., Griffin,K., Williams,R.S., Glover,J.N. and Parvin,J.D. (2006) BRCA1 DNA-binding activity is stimulated by BARD1. Cancer Res., 66, 2012-2018.
34. Wu,L.C., Wang,Z.W., Tsan,J.T., Spillman,M.A., Phung,A., Xu,X.L., Yang,M.C., Hwang,L.Y., Bowcock,A.M. and Baer,R. (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genet., 14, 430-440.
35. 1/S arrest following ionizing radiation-induced DNA damage. J. Biol. Chem., 279, 31251-31258.
36. Cooper,M.P., Machwe,A., Orren,D.K., Brosh,R.M., Ramsden,D. and Bohr,V.A. (2000) Ku complex interacts with and stimulates the Werner protein. Genes Dev., 14, 907-912.
37. Wyllie,F.S., Jones,C.J., Skinner,J.W., Haughton,M.F., Wallis,C., Wynford-Thomas,D., Faragher,R.G. and Kipling,D. (2000) Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nature Genet., 24, 16-17.
38. Yannone,S.M., Roy,S., Chan,D.W., Murphy,M.B., Huang,S., Campisi,J. and Chen,D.J. (2001) Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J. Biol. Chem., 276, 38242-38248.
39. Karmakar,P., Piotrowski,J., Brosh,R.M.,Jr, Sommers,J.A., Miller,S.P., Cheng,W.H., Snowden,C.M., Ramsden,D.A. and Bohr,V.A. (2002) Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation. J. Biol. Chem., 277, 18291-18302.
40. Thompson,L.H. (2005) Unraveling the Fanconi anemia-DNA repair connection. Nature Genet., 37, 921-922.
41. Lan,L., Nakajima,S., Komatsu,K., Nussenzweig,A., Shimamoto,A., Oshima,J. and Yasui,A. (2005) Accumulation of Werner protein at DNA double-strand breaks in human cells. J. Cell. Sci., 118, 4153-4162.
42. Cheng,W.H., Sakamoto,S., Fox,J.T., Komatsu,K., Carney,J. and Bohr,V.A. (2005) Werner syndrome protein associates with gamma H2AX in a manner that depends upon Nbs1. FEBS Lett., 579, 1350-1356.
43. Pichierri,P., Franchitto,A. and Rosselli,F. (2004) BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. EMBO J., 23, 3154-3163.
44. Davalos,A.R. and Campisi,J. (2003) Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks. J. Cell. Biol., 162, 1197-1209.
45. Prince,P.R., Ogburn,C.E., Moser,M.J., Emond,M.J., Martin,G.M. and Monnat,R.J.,Jr (1999) Cell fusion corrects the 4-nitroquinoline 1-oxide sensitivity of Werner syndrome fibroblast cell lines. Hum. Genet., 105, 132-138.
46. Constantinou,A., Tarsounas,M., Karow,J.K., Brosh,R.M., Bohr,V.A., Hickson,I.D. and West,S.C. (2000) Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep., 1, 80-84.
47. Cobb,J.A., Schleker,T., Rojas,V., Bjergbaek,L., Tercero,J.A. and Gasser,S.M. (2005) Replisome instability, fork collapse, and gross chromosomal rearrangements arise synergistically from Mec1 kinase and RecQ helicase mutations. Genes Dev., 19, 3055-3069.
48. Bryant,H.E., Schultz,N., Thomas,H.D., Parker,K.M., Flower,D., Lopez,E., Kyle,S., Meuth,M., Curtin,N.J. and Helleday,T. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature, 434, 913-917.
49. Farmer,H., McCabe,N., Lord,C.J., Tutt,A.N., Johnson,D.A., Richardson,T.B., Santarosa,M., Dillon,K.J., Hickson,I., Knights,C. et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 434, 917-921.
50. von Kobbe,C., Harrigan,J.A., May,A., Opresko,P.L., Dawut,L., Cheng,W.H. and Bohr,V.A. (2003) Central role for the Werner syndrome protein/ poly(ADP-ribose) polymerase 1 complex in the poly(ADP-ribosyl)ation pathway after DNA damage. Mol. Cell Biol., 23, 8601-8613.
51. von Kobbe,C., Harrigan,J.A., Schreiber,V., Stiegler,P., Piotrowski,J., Dawut,L. and Bohr,V.A. (2004) Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein. Nucleic Acids Res., 32, 4003-4014.
52. Cao,L., Li,W., Kim,S., Brodie,S.G. and Deng,C.X. (2003) Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev., 17, 201-213.
53. Sedelnikova,O.A., Horikawa,I., Zimonjic,D.B., Popescu,N.C., Bonner,W.M. and Barrett,J.C. (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell. Biol., 6, 168-170.
54. Risinger,M.A. and Groden,J. (2004) Crosslinks and crosstalk; Human cancer syndromes and DNA repair defects. Cancer Cell, 6, 539-545.